Telix Pharmaceuticals Ltd — Capital/Financing Update 2025

Jul 8, 2025

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

TELIX PHARMACEUTICALS LIMITED

Announcement Type

New announcement

Date of this announcement

Wednesday July 09, 2025

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
TLX	ORDINARY FULLY PAID	16,445	26/06/2025

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 7

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of entity

TELIX PHARMACEUTICALS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

Registration number

ACN 616620369

1.3 ASX issuer code

TLX

1.4 The announcement is

New announcement

1.5 Date of this announcement

9/7/2025

Appendix 2A - Application for quotation of securities

2 / 7

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

Appendix 2A - Application for quotation of securities

3 / 7

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37

TO (Existing Class) ASX +security code and description TLX : ORDINARY FULLY PAID Please state the number of options The first date the options were The last date the options were that were exercised or other exercised or other +convertible exercised or other +convertible +convertible securities that were securities were converted securities were converted converted 23/6/2025 26/6/2025 12,595 Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? No The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: An issue of new +securities The underlying +securities being received by the holder are: Intended to be, but are not yet, quoted by ASX Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No

Issue date

26/6/2025

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Appendix 2A - Application for quotation of securities

4 / 7

Appendix 2A - Application for quotation of securities

Issue details

==> picture [21 x 22] intentionally omitted <==

==> picture [540 x 144] intentionally omitted <==

----- Start of picture text -----

Number of +securities to be quoted
12,595
Are the +securities being issued for a cash consideration?
Yes
In what currency is the cash consideration being paid? What is the issue price per +security?
AUD - Australian Dollar AUD 5.37000000
Any other information the entity wishes to provide about the +securities to be quoted
----- End of picture text -----

Existing +securities converting into additional +securities in an existing class
FROM (Existing Class)
ASX +security code and description
TLXAO : SHARE APPRECIATION RIGHTS
TO (Existing Class)
ASX +security code and description
TLX : ORDINARY FULLY PAID
Please state the number of options	The first date the options were	The last date the options were
that were exercised or other	exercised or other +convertible	exercised or other +convertible
+convertible securities that were	securities were converted	securities were converted
converted	23/6/2025	26/6/2025
5,058
Is this all of the options or other +convertible securities on issue of that type		(ie have all of those options now been
exercised or have all of those convertible securities now been converted)?
No
The right of the holder of the options or other +convertible securities to receive the +underlying securities is being
satisfied by:
An issue of new +securities
The underlying +securities being received by the holder are:
Intended to be, but are not yet, quoted by ASX
Were the options being exercised or	other +convertible securities being converted issued under an +employee
incentive scheme?
Yes
Are any of the options being exercised or other +convertible securities being		converted held by +key management
personnel (KMP) or an +associate?
No

Issue date

26/6/2025

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Appendix 2A - Application for quotation of securities

5 / 7

Appendix 2A - Application for quotation of securities

Issue details

==> picture [21 x 22] intentionally omitted <==

Number of +securities to be quoted

3,850

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

Shares issued from exercise of vested 2022 PSARs under Telix EIP valued in accordance with the independent Black Scholes methodology disclosed in the AGM Notice of Meeting held 18 May 2022.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

6.150000

Any other information the entity wishes to provide about the +securities to be quoted

Refer https://ir.telixpharma.com/reports for AGM documentation and also Telix 2024 Remuneration report within the 2024 Annual Report

Appendix 2A - Application for quotation of securities

6 / 7

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

+securities subject of this application)
	Total number of
ASX +security code and description	+securities on issue
TLX : ORDINARY FULLY PAID	338,399,059
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
TLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL	80,000
TLXAR : PERFORMANCE RIGHTS	9,965,235
TLXAP : SHARE RIGHTS	1,440,000
TLXAO : SHARE APPRECIATION RIGHTS	15,700,490
TLXAT : CONVERTIBLE NOTES	3,250
TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37	242,397
TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL	100,000
TLXAU : DEFERRED SHARE RIGHTS EX-US 2024	10,561
TLXAV : DEFERRED SHARE RIGHTS US 2024	10,342
TLXAW : PERFORMANCE SHARE APPRECIATION RIGHTS US 2025	2,881,250
TLXAL : OPTION EXPIRING 27-JAN-2026 EX $4.38	289,225
TLXAS : PERFORMANCE SHARE INCENTIVE RIGHTS	440,000

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Appendix 2A - Application for quotation of securities

7 / 7